Article
Current treatment options for meningioma.
Expert review of neurotherapeutics - 1 Mar 2018
Apra Caroline, Peyre Matthieu, Kalamarides Michel
Abstract excerpt
INTRODUCTION: With an annual incidence of 5/100,000, meningioma is the most frequent primary tumor of the central nervous system. Risk factors are radiotherapy and hormone intake. Most meningiomas are grade I benign tumors, but up to 15% are atypical and 2% anaplastic according to the WHO 2016 histological criteria. Areas covered: This review details the current standard therapy based on international guidelines...
Topics
Join the communities discussing this publication.